Rufeng Dai

829 total citations
14 papers, 71 citations indexed

About

Rufeng Dai is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Rufeng Dai has authored 14 papers receiving a total of 71 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 6 papers in Nephrology. Recurrent topics in Rufeng Dai's work include Lipid metabolism and disorders (7 papers), Renal and related cancers (6 papers) and Renal Diseases and Glomerulopathies (6 papers). Rufeng Dai is often cited by papers focused on Lipid metabolism and disorders (7 papers), Renal and related cancers (6 papers) and Renal Diseases and Glomerulopathies (6 papers). Rufeng Dai collaborates with scholars based in China, United States and United Kingdom. Rufeng Dai's co-authors include Haimei Liu, Hong Xu, Yi­hui Zhai, Jia Rao, Yi Lin, Xiliang Zha, Xiaoyan Fang, Qian Shen, Junchao Liu and Bixia Zheng and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research and Cell Death and Disease.

In The Last Decade

Rufeng Dai

10 papers receiving 71 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rufeng Dai China 5 42 39 23 8 7 14 71
Nazareno Carullo Italy 6 16 0.4× 16 0.4× 17 0.7× 5 0.6× 6 0.9× 13 71
Azra Durak-Nalbantić Bosnia and Herzegovina 5 42 1.0× 11 0.3× 12 0.5× 5 0.6× 6 0.9× 19 76
Е. В. Колмакова Russia 3 19 0.5× 15 0.4× 37 1.6× 3 0.4× 10 1.4× 4 77
Joanne Laycock United Kingdom 2 9 0.2× 42 1.1× 19 0.8× 5 0.6× 13 1.9× 3 82
Venla Kurra Finland 3 12 0.3× 43 1.1× 15 0.7× 3 0.4× 3 0.4× 8 97
Pedro Gomes Portugal 6 29 0.7× 13 0.3× 18 0.8× 3 0.4× 7 1.0× 19 81
LI Fen China 5 7 0.2× 35 0.9× 21 0.9× 4 0.5× 12 1.7× 20 81
Tomasz J Guzik Poland 3 26 0.6× 5 0.1× 14 0.6× 5 0.6× 5 0.7× 11 76
Edit Gara Hungary 6 25 0.6× 11 0.3× 21 0.9× 4 0.5× 9 1.3× 11 70
Soroush Masrouri Iran 6 19 0.5× 5 0.1× 27 1.2× 14 1.8× 5 0.7× 27 92

Countries citing papers authored by Rufeng Dai

Since Specialization
Citations

This map shows the geographic impact of Rufeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufeng Dai more than expected).

Fields of papers citing papers by Rufeng Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rufeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufeng Dai. The network helps show where Rufeng Dai may publish in the future.

Co-authorship network of co-authors of Rufeng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Rufeng Dai. A scholar is included among the top collaborators of Rufeng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rufeng Dai. Rufeng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Dai, Rufeng, Jingjia Zhang, Tianyi Liu, et al.. (2025). Genitourinary defects, anxiety and aggressive-like behavior and glucose metabolism disorders in Zmym2 mutant mice with inserted piggyBac transposon. Frontiers in Cell and Developmental Biology. 13. 1523266–1523266.
2.
Liu, Jiaojiao, et al.. (2025). From mutation to symptoms: a multi-center study on HNF1B-related nephropathy in Chinese children. BMC Nephrology. 26(1). 701–701.
3.
Liu, Jialu, Shanshan Xue, Yaxin Li, et al.. (2024). GEN1 as a risk factor for human congenital anomalies of the kidney and urinary tract. Human Genomics. 18(1). 41–41. 2 indexed citations
4.
Liu, Jiaojiao, Xiaowen Wang, Tong Shen, et al.. (2024). Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria. Renal Failure. 46(2). 2423845–2423845.
5.
Buerger, Florian, Chunyan Wang, Bixia Zheng, et al.. (2023). Prioritization of Monogenic Congenital Anomalies of the Kidney and Urinary Tract Candidate Genes with Existing Single-Cell Transcriptomics Data of the Human Fetal Kidney. ˜The œNephron journals/Nephron journals. 147(11). 685–692.
6.
Liu, Junchao, Rufeng Dai, Jiaojiao Liu, et al.. (2023). Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in children. Frontiers in Pediatrics. 11. 1113484–1113484. 2 indexed citations
7.
Ni, Jiajia, Qianqian Ma, Rufeng Dai, et al.. (2022). Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage. Cell Death and Disease. 13(10). 867–867. 5 indexed citations
8.
Liu, Haimei, Rufeng Dai, Jiaojiao Liu, et al.. (2021). PPARα agonist exerts protective effects in podocyte injury via inhibition of the ANGPTL3 pathway. Experimental Cell Research. 407(2). 112753–112753. 2 indexed citations
9.
Zheng, Bixia, Chunyan Wang, Wilfred Wu, et al.. (2021). A truncating NRIP1 variant in an Arabic family with congenital anomalies of the kidneys and urinary tract. American Journal of Medical Genetics Part A. 188(1). 310–313. 4 indexed citations
10.
Zheng, Bixia, Chunyan Wang, Rufeng Dai, et al.. (2021). Whole-exome sequencing identifiesFOXL2,FOXA2andFOXA3as candidate genes for monogenic congenital anomalies of the kidneys and urinary tract. Nephrology Dialysis Transplantation. 37(10). 1833–1843. 5 indexed citations
11.
Dai, Rufeng, et al.. (2019). Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on adriamycin-induced nephropathy in mice. Biochemical and Biophysical Research Communications. 516(3). 812–818. 5 indexed citations
12.
Dai, Rufeng, Haimei Liu, Junchao Liu, et al.. (2019). Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss. BMC Nephrology. 20(1). 185–185. 15 indexed citations
13.
Liu, Jiaojiao, Hong Xu, Rufeng Dai, et al.. (2015). Potential function of angiopoietin-like protein 3 in hyperlipidemia of nephrotic syndrome. 31(9). 669–673. 1 indexed citations
14.
Dai, Rufeng, Yi Lin, Haimei Liu, et al.. (2015). A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro. BMC Nephrology. 16(1). 38–38. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nazareno Carullo Breakdown of academic impact, for papers by Azra Durak-Nalbantić Breakdown of academic impact, for papers by Е. В. Колмакова Breakdown of academic impact, for papers by Joanne Laycock Breakdown of academic impact, for papers by Venla Kurra Breakdown of academic impact, for papers by Pedro Gomes Breakdown of academic impact, for papers by LI Fen Breakdown of academic impact, for papers by Tomasz J Guzik Breakdown of academic impact, for papers by Edit Gara Breakdown of academic impact, for papers by Soroush Masrouri
Rankless by CCL
2026